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Summary/Abstract
Chronic low back pain is a condition that current health care provision is failing and we suggest that
recent evidence from the interventional pain medicine field points to what these failings are.
Radiofrequency denervation is performed on the presumption that denervation of a peripheral structure
will eradicate or significantly reduce pain and improve function. The results of six moderately sized and
well conducted clinical trials that demonstrate no efficacy and no real-world effectiveness for
denervation procedures are a stark illustration of how flawed this approach is. We suggest that these
results represent a line-in-the-sand for back pain research and management. This is a clear signal to
finally abandon research agendas and management paradigms that focus primarily on nociception and
instead, truly embrace the biopsychosocial model of pain.
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Persistent low back pain (LBP) is the leading cause of disability globally, for which ever larger increases
in health care expenditure have not made a difference in terms of prevalence or burden [1]. It is
unquestionable that current health care is failing individuals with chronic LBP and we contend that
recent evidence from the interventional pain medicine field points clearly to what these failings are.
Radiofrequency denervation does not work for LBP
There has been remarkable growth in the use of interventional pain medicine procedures to manage
chronic LBP, particularly radiofrequency denervation [2]. In this approach, various diagnostic practices
are used to identify a peripheral ‘nociceptive driver’ with the presumption that denervation of the
peripheral structure will eradicate or significantly reduce pain and improve function [3]. The growth in
the use of radiofrequency denervation is surprising given that, until recently, the evidence base was
equivocal [2] and based on conflicting results from a limited number of small trials.
A welcome addition to the field was recently provided by Juch et al. [2], who reported on the
outcome of three large clinical trials of neuroablative procedures in chronic LBP. All three trials
compared guideline based physical rehabilitation to rehabilitation with the addition of radiofrequency
denervation. Despite employing a methodology that is likely to inflate the effect of the intervention, the
results are markedly negative, with no clinically worthwhile benefit for pain or function demonstrated
with facet denervation, sacroiliac joint denervation or a combination of denervation procedures.
Perhaps more striking is that average pain intensity varied little across the 12-month follow up in all
three studies and rarely did more than 50% of participants achieve greater than 30% reduction in pain
intensity.
The studies demonstrate that a large group of participants with chronic LBP who were: 1)
selected because their treating physician suspected that their problem originated from a peripheral tissue
source; 2) positive on a diagnostic block (albeit a single block) and 3) included only if there were no
apparent psychological co-morbidities or work-related issues, obtained almost no benefit from
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denervation of the identified peripheral tissue. These findings are in accordance with a recent, more
methodologically rigorous series of studies that found no difference between true and sham
interventions for denervation of the facet joints [4], the lumbar disc [5] or the sacroiliac joints [6].
How do the findings impact our understanding of LBP?
While we anticipate commentary around the recent findings will focus on the diagnostic
process, we urge those in the chronic LBP field to consider how remarkable the results are for our
theoretical understanding of the problem. Despite decades of research illustrating the equivocal link
between nociception and pain [3], as well as the disparity between reported pain and disability [3], many
in the back pain community continue to see the management of nociception as the primary focus in the
management of LBP. The results of six moderately sized and well conducted clinical trials that
demonstrate no efficacy [4–6] and no real world effectiveness [2] for denervation procedures are a stark
illustration of how flawed this approach is. This series of studies utilised a version of what is probably
the best clinical tool available for identifying a peripheral nociceptive driver; certainly better than a
careful interview, physical examination or any type of structural imaging. This diagnostic process was
coupled with what is likely the best clinical tool we have for blocking peripheral nociceptive input, one
that is better than any medication, biologic, manual technique, electrophysical modality or exercise in
current use. Crucially, this approach offered little benefit to people with chronic LBP.
How do the findings impact the management of LBP?
We suggest that the results represent a line-in-the-sand moment for LBP research and
management. This is a clear signal to finally abandon research agendas and management paradigms that
equate pain to nociception, and to embrace the perspective that LBP emerges from multiple interacting
domains [7]. In this contemporary biopsychosocial perspective, the ‘bio’ is regarded to be more than
just structural pathology and encompasses changes across a range of body systems, including the central
nervous system [8,9]. The ‘psychosocial’ captures the beliefs, knowledge, attitudes, thoughts and
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meaning of one’s pain, one’s mood and the sociological context; as these are associated with pain and
disability [9]. Rehabilitation needs to make sense of these factors for the individual [10] and employ a
person-centred reactivation process that seeks to decrease the perceived need for protection, build
confidence and restore hope. Promising approaches could include, for example, reconceptualising the
individuals’ understanding of pain and disability, normalising the way the back is represented within the
central nervous system and progressively improving the capacity of the body to cope with activities of
daily living [8,11,12].
George Engel broadcast the fallibility of a model of care that addresses only tissue pathology
[13] – surely it is time we actioned his recommendations and really embrace the biopsychosocial model
of pain.
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